Home Chinese Virus We could have told them months ago

We could have told them months ago

Author

Date

Category

Oxford University to test potential COVID-19 ‘wonder drug’ Ivermectin

LONDON: Oxford University researchers are planning to trial a drug that has shown signs of reducing COVID-19 deaths in developing countries.The Principle trial is aiming to find a drug that works soon after virus symptoms appear in a patient, and one that is most effective during the primary stages of the illness, The Times reported.The trial is assessing Ivermectin, a medicine used on livestock and people who have been infected by parasitic worms, which has been hailed by some as a “wonder drug” with the potential to save thousands of lives, the report added.Other scientists said the drug had not been assessed properly and that the full extent of its efficacy was not yet known.“It has potential antiviral properties and anti-inflammatory properties and there have been quite a few smaller trials conducted in low and middle- income countries, showing that it speeds recovery, reduces inflammation and reduces hospitalisation,” said Chris Butler, professor of primary care at Oxford and co-chief of the Principle trial. “But there’s a gap in the data. There’s not been a really rigorous trial.”

Medicine used for parasitic worm infections Other scientists said the drug had not been assessed properly LONDON: Oxford University researchers are planning to trial a drug that has shown signs of reducing COVID-19 deaths in developing countries.

The Principle trial is aiming to find a drug that works soon after virus symptoms appear in a patient, and one that is most effective during the primary stages of the illness, The Times reported.

The trial is assessing Ivermectin, a medicine used on livestock and people who have been infected by parasitic worms, which has been hailed by some as a “wonder drug” with the potential to save thousands of lives, the report added.

Other scientists said the drug had not been assessed properly and that the full extent of its efficacy was not yet known.

“It has potential antiviral properties and anti-inflammatory properties and there have been quite a few smaller trials conducted in low and middle- income countries, showing that it speeds recovery, reduces inflammation and reduces hospitalisation,” said Chris Butler, professor of primary care at Oxford and co-chief of the Principle trial. “But there’s a gap in the data. There’s not been a really rigorous trial.”

The medicine works by blocking the entry of a protein into a cell’s nuclei, limiting the replication capacity of the virus, and initial analysis from the World Health Organization has shown promising signs.

“It could save thousands of lives a day,” said Paul Marik, from the Eastern Virginia Medical School. “The data is compelling: across Mexico, India and South America, mortality has fallen.”

Peter Horby, the Oxford University professor who helped to set up the UK’s largest COVID-19 trials, said this month the latest data was “interesting, perhaps encouraging, but not yet convincing.”

Most breakthroughs in coronavirus treatments to date work on patients who are already suffering in the later stages of the illness, but Butler and his team are hoping to find a medicine that can prevent the virus from taking hold within its host.

The trial is looking for people aged 65 and over, or those aged over 50 who have underlying health conditions, through general practitioners, online, and through the UK’s NHS Test and Trace system, The Times said.

Previous articleHave Your Say
Next articleBlue Lightning

9 COMMENTS

  1. I smell a fricking great dirty rat coming at us from northland ,are we going to be told by the tilty headed creature “see how the tracing app works,from now on you WILL use it or be arrested” .
    Which one of the Labour caucus fuckwits will explain this monumental cockup ?

    12

    0

  2. Big pharmas quest for billions of dollars costs hundreds of thousands of lives… quite typical really and this wont be the 1st time theyve ignored the cheap and effective option.

    The general population is just viewed as guinea pigs for the elite and corrupt.

    12

    0

  3. Now that they have got rid of President Trump they will start to look at this and HCQ but mostly for developing countries not us as we can all afford to pay for the expensive, less effective drugs
    so damn sad these lefties want to ruin our world and turn it into a shithole

    4

    0

    • ivomec has been around since the 70s and hcq has caused no problems since the 50s
      if only President Trump had said that hcq was useless we would have all had access to it

      oh wait no they want to scare us into submission

      3

      0

Recent posts

Blood Clots

Blood Clots: Now Airlines Warning COVID Vaccinated Not To Fly! Martin Armstrong We are starting to come full circle. Now airlines in Spain and Russia are warning people...

Blackouts Coming?

THE BLACKOUT AGENDA By Viv Forbes Solar power fails every day from sunset to sunrise as well as during rain, hail, snow or dust storms. No...

Scientists Should Never Be Trusted Again

Scientists Admit Covering Up Lab Leak Theory to Avoid Being ‘Associated’ with Trump By way of an unforgivable (but very revealing) act of silence, several...

Recent comments

B Venton on Have Your Say
Braybots nemesis on Have Your Say
Braybots nemesis on Have Your Say
waikatogirl on Have Your Say
Sooty on Have Your Say
Braybots nemesis on Have Your Say
Sooty on Have Your Say
Braybots nemesis on Have Your Say

The way we all feel about this useless government

Hamilton
scattered clouds
13.4 ° C
14.6 °
12.6 °
78 %
0.5kmh
33 %
Thu
13 °
Fri
15 °
Sat
17 °
Sun
15 °
Mon
14 °
NZD - New Zealand Dollar
USD
1.4177
EUR
1.6905
AUD
1.0740
CAD
1.1521
GBP
1.9793
JPY
0.0128
CNY
0.2188
INR
0.0191